Essa Pharma Inc. (EPIX) SEC Filing 6-K Foreign Issuer report for the period ending Monday, May 14, 2018

SEC Filings

Essa Pharma Inc.

CIK: 1633932 Ticker: EPIX

View differences made from one to another to evaluate Essa Pharma Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Essa Pharma Inc..


Assess how Essa Pharma Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Essa Pharma Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: EPIX
CIK: 1633932
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001279569-18-001059
Submitted to the SEC: Mon May 14 2018 7:57:57 PM EST
Accepted by the SEC: Tue May 15 2018
Period: Monday, May 14, 2018
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: